Complementary Therapy Hormonal Treatment and Plant
Transcription
Complementary Therapy Hormonal Treatment and Plant
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer © AGO e.V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 Complementary Therapy Hormonal Treatment and Plant Alternatives in Breast Cancer Survivors Survivorship – Complementary Therapy – Hormonal Treatment and (Plant) Alternatives in Breast Cancer Survivors - Survivorship © AGO e.V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 Version 2002: Hanf / Göhring Version 2003–2009: Bauerfeind / Gerber / Hanf / Janni / von Minckwitz / Oberhoff / Scharl / Thomssen Version 2010: Oberhoff / Janni Advice on nutritional facts by Prof. Dr. Gabriele Stangl, Martin-LutherUniversity Halle-Wittenberg, Germany „Alternative“ Therapies © AGO e.V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 CAM UCT Complementary + alternative medicine Unconventional Thx Complementary Alternative Unconventional In addition to scientifically based medicine Instead of scientifically based medicine Unproven outsider methods Modifiable Lifestyle Factors Nutrition after Breast Cancer Diagnosis © AGO e.V. Oxford / AGO in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 LoE / GR Adherence to normal BMI (improves prognosis – DFS/OS) 2b Low fat diet (improves prognosis – DFS - espc. postmenopausal, ER neg.; <20% fat calories, only with dietary counseling!) 1b(-) B + Adherence to general nutrition guidelines Dietary extremes (are associated with less favourable outcomes) B ++ 2a B + 1b B -- Modifiable Lifestyle Factors © AGO e.V. in der DGGG e.V. sowie in der DKG e.V. Oxford / AGO Guidelines Breast Version 2010.1.1 LoE / GR Physical Exercise 2b B ++ (Equivalents to 3–5 hrs moderate pace walking per week improves DFS and OS, quality of life, cardiorespiratory fitness, physical functioning and fatigue ) Smoking 2b B - Reg. alcohol consumption (>6 g/die) 2b B - Complementary Treatment Prevention of Recurrence © AGO e.V. in der DGGG e.V. sowie in der DKG e.V. While on anti-cancer treatment: beware of drug interactions Oxford AGO LoE / GR Guidelines Breast Version 2010.1.1 Orthomolecular substances (Selenium, Zinc...) 5 D - 2b B - High-dose vitamines 3b Proteolytic enzymes 5 (Papain, Trypsin, Chymotrypsin) Soy (Phytoestrogenes) 5 Black Cohosh (Cimicifuga racemosa) 2b Mistletoe (Viscum album) 1a Thymus, splenic peptide 5 Oxygen- and ozone therapy 5 Antioxidant supplements 2b Cancer bush (Sutherlandia frutescens), Devil's claw (Harpagophytum procumbens), Rooibos tea (Aspalathus linearis), Bambara groundnut (Vignea subterranean) 5 C D - D C B D D B +/+/- D - Selenium for alleviating side effects of therapy Hormone (Replacement) Therapy (HT) of Estrogen Deficiency after Diagnosis of Breast Cancer © AGO Oxford / AGO e.V. in der DGGG e.V. sowie in der DKG e.V. LoE / GR Guidelines Breast Version 2010.1.1 Endocrine responsive disease (HT may increase risk) Endocrine non-responsive disease (apparently no risk increase) Endocrine responsive disease: combined treatment TAM plus low-dose-HT Tibolone Topical vaginal application of Estriol Estradiol during AI therapy 1b B- 2a B +/- 2b B +/-* 1b A-- 5 4 D +/C- *Study participation recommended Contraceptive Options for Women after Diagnosis of Breast Cancer © AGO Oxford / AGO LoE / GR e.V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 Barrier methods Sterilization (tubal ligation/vasectomy) Non-hormonal intrauterine devices (IUDs) Levonorgestrel-releasing IUDs Removal in newly diagnosed patients Timing methods Injectable progestin-only contraceptives Progestin-only oral contraceptives Combined oral contraceptives 5 5 5 5 D D D D + + + - 4 D +/- 5 5 5 5 D D D D - No trial included women after diagnosis of breast cancer, non-estrogen containing devices do not increase the risk to develop primary breast cancer Alternatives to Reduce Menopausal Symptoms after BC (1) © AGO e.V. Oxford / AGO LoE / GR in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 General approaches: Physical exercise 2b D + Comprehensive intervention (yoga, hypnosis, education, counseling, non-hormonal drugs) 1b A ++ Vaginal lubricants and moisturizers 4 Acupuncture 1a A +/- C + Alternatives to Reduce Menopausal Symptoms after BC (2) © AGO Oxford / AGO LoE / GR e.V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 Medical approaches: Selective serotonin reuptake inhibitors and serotonin-(noradrenalin) reuptake inhibitors (SSRI-SNRI): reduce hot flashes in BC patients 1st choice: venlafaxine, paroxetine 1a 2nd choice: desvenlafaxine, sertraline, fluoxetine 1b 3rd choice: duloxetine, escitalopram 1b Gabapentin (BC and TAM-use) 1a Clonidin (BC and TAM-use) 1a MPA (i.m. 500 mg single shot) (most potent, but endocrine agent!) 1b Vitamine E 1b A A A A A + +/+/+ + A A +/+/- Botanical Approaches to Reduce Menopausal Symptoms © AGO e.V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2010.1.1 While anti-cancer treatment: Beware of drug interactions! Oxford AGO LoE / GR Soy-derived phytoestrogens – isoflavonoids (might stimulate BC especially in endocrine responsive disease) 1b A - Flaxseed-supplementation (40 g/d) 3 D +/- Black Cohosh for hot flushes (Effectiveness could not be clearly shown) 1b A +/- St. Johns Wort in combination-therapy (pharmacokinetic interference with cyctotoxic drugs and tyrosinkinase inhibitors) 1b A -- Kava-Kava (Piper methysticum) 5 D -- Red Clover leaf (Trifolium pratense) 5 D -- Dong Quai root (Angelica sinensis) 5 D -- Ginseng root (Panax ginseng or P. quinquefolius) 5 D -